Combination of monoclonal antibodies targeting type 2 inflammation for severe asthma and eosinophilic granulomatosis with polyangiitis
F. Davanzo, Maria Rita Marchi, Luca Iorio, Michela Bortoli, Andrea Doria, Roberto Padoan
Topics & Concepts
MepolizumabMedicineOmalizumabBenralizumabHypereosinophiliaAsthmaDupilumabGranulomatosis with polyangiitisEosinophilicAdverse effectInternal medicineEosinophiliaDermatologyImmunologyVasculitisEosinophilPathologyImmunoglobulin EAntibodyDiseaseAsthma and respiratory diseasesAllergic Rhinitis and SensitizationUrticaria and Related Conditions